Twelve thio- and amino- benzoquinones (3a-d, 5a, 5b, 7d, 8d, 10e, 11e, 13e and 13f) were synthesized from benzoquinones (p-benzoquinone 1, p-toluquinone 6 and 2-tert-butyl-1,4-benzoquinone 12) with thiols or primary amines. Among them, compounds 3a-3d and 5a,b have mono(thio)- and bis(thio)- substituted-benzoquinone structures, respectively. The compounds 2-(3,4-dimethylphenylthio)-6- (tetradecylthio)cyclohexa-2,5-diene-1,4-dione (5a) and 2-(3,4- dimethoxyphenylthio)-6-(tetradecylthio)cyclohexa-2,5-diene-1,4-dione, (5b) include two different thio- groups in each of them. Compounds 7d and 8d have 5-methyl- and 6-methyl- 2-thio-substituted-benzoquinone structures, respectively, while compounds 10e and 11e have 5-methyland 6-methyl- 2-benzylamino-substituted-benzoquinone structures, respectively. The compounds 13e and 13f include the 6-tert-butyl-2- benzylamino-substituted-1,4-benzoquinone skeleton. Twelve products were characterized, using FTIR, UV/Vis, MS(ESI), 1H and 13C NMR and elemental analysis. Antibacterial activity of compound 3d has been evaluated against Escherichia coli (E. coli)
No takes yet. Share an insight, caveat, or question.
Ayşecik Kaçmaz (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: